Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CFN Enterprises (CNFN) Cash & Current Investments (2016 - 2025)

CFN Enterprises' Cash & Current Investments history spans 16 years, with the latest figure at $197951.0 for Q4 2025.

  • Quarterly results put Cash & Current Investments at $197951.0 for Q4 2025, down 47.05% from a year ago — trailing twelve months through Dec 2025 was $197951.0 (down 47.05% YoY), and the annual figure for FY2025 was $197951.0, down 47.05%.
  • Cash & Current Investments for Q4 2025 was $197951.0 at CFN Enterprises, up from $102324.0 in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $1.8 million in Q2 2025 to a low of $38839.0 in Q1 2023.
  • The 5-year median for Cash & Current Investments is $197951.0 (2025), against an average of $398226.7.
  • The sharpest move saw Cash & Current Investments soared 1528.37% in 2021, then tumbled 85.03% in 2024.
  • Year by year, Cash & Current Investments stood at $236545.0 in 2021, then crashed by 77.71% to $52730.0 in 2022, then surged by 88.11% to $99192.0 in 2023, then skyrocketed by 276.88% to $373834.0 in 2024, then crashed by 47.05% to $197951.0 in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $197951.0, $102324.0, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.